<DOC>
	<DOCNO>NCT02147977</DOCNO>
	<brief_summary>Background : End Stage Renal Disease ( ESRD ) patient extremely high mortality lead cause death cardiovascular disease account 50 % death . It estimate one third due arrhythmia . Previous study reveal high risk various arrhythmias dialysis patient prevalence uncertain . Atrial fibrillation common arrhythmia among patient ESRD . The arrhythmia often asymptomatic , risk stroke increase dramatically annual mortality double . Autonomic cardiac dysfunction often see patient ESRD , express attenuated Heart Rate Variability ( HRV ) measure variation time interval heart beat . Attenuated 24 hour HRV associate increase risk sudden cardiac death general population among patient ESRD . N-3 polyunsaturated fatty acid ( PUFAs ) fish fish oil supplement show increase HRV reduce risk various ventricular supraventricular arrhythmia study , effect sparsely investigated high risk patient ESRD , low intake n-3 PUFAs . Objective : The purpose study investigate effect n-3 PUFA supplementation HRV arrhythmias dialysis patient . Hypothesis : n-3 PUFA supplementation increase 24 hour HRV dialysis patient . n-3 PUFA supplementation reduces level Supraventricular tachycardia , premature atrial complex ( PACs ) premature ventricular complex ( PVCs ) chronic dialysis patient . Design : Randomized double-blind , placebo control trial Study participant : 140 dialysis patient Aalborg University Hospital Vendsyssel Hospital , Hj√∏rring Denmark . Inclusion time : Summer 2014 Fall 2015 Methods : The patient allocate 3 month treatment supplement 2 g n-3 PUFAs placebo ( olive oil ) . The following data register baseline 3 month treatment : Demographics medical history , Standard ECG-12 , blood pressure , blood sample , 48 hour ambulatory ECG Holter recording , Intake n-3 PUFAs ( assessed questionnaire blood measurement ) . Perspective : A positive result study might make possible achieve reduction arrhythmia mortality high risk patient cheap well tolerate nutritional supplement .</brief_summary>
	<brief_title>Effects Marine n-3 Fatty Acids Heart Rate Variability Arrhythmias Patients Receiving Chronic Dialysis</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Dialysis &gt; 3 month Age &gt; 18 year Signed informed consent Patients able consent . Known allergy content olive fish oil capsule . Remaining life expectancy &lt; 3 month . Pregnancy ( positive SHCG ) test perform case doubt .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Renal Dialysis</keyword>
	<keyword>Arrhythmias Cardiac</keyword>
	<keyword>Death Sudden Cardiac</keyword>
	<keyword>Fatty Acids Omega 3</keyword>
</DOC>